| James Mattison Blalock, MD | |
|
608 Nw 9th St, Suite 6110, Oklahoma City, OK 73102-1049 | |
| (405) 272-6909 | |
| (405) 231-3723 |
| Full Name | James Mattison Blalock |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Pulmonary Disease |
| Location | 608 Nw 9th St, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093754251 | NPI | - | NPPES |
| 100071500B | Medicaid | OK | |
| P00332846 | Other | OK | INDIVIDUAL RAILROAD MCARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 12285 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| James Mattison Blalock, MD Po Box 269086, Oklahoma City, OK 73126 Ph: (405) 231-3857 | James Mattison Blalock, MD 608 Nw 9th St, Suite 6110, Oklahoma City, OK 73102-1049 Ph: (405) 272-6909 |
News Archive
A cataract is a cloud or film that can form on the lens of a person's eye. The presence of a cataract can degrade the quality of one's vision by blocking and scattering light as it enters the eye. It is often associated with chronic exposure to ultraviolet radiation.
The real-time measuring capability of a PTR-MS trace gas analyzer is ideally suited for continuous VOC monitoring but also for rapid analysis of discrete samples within seconds. The new IONICON autosampler for PTR-MS enables automated screening of hundreds of sample vials.
A promising new test is detecting prostate cancer more precisely than current tests, by identifying molecular changes in the prostate specific antigen (PSA) protein, according to Cleveland Clinic research presented today at the American Urological Association annual meeting.
Sangamo Therapeutics, Inc. and Pfizer Inc. today announced a collaboration for the development of a potential gene therapy using zinc finger protein transcription factors (ZFP-TFs) to treat amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) linked to mutations of the C9ORF72 gene.
› Verified 3 days ago
Evelyn Lorents, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 920 Sl Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-5963 | |
Patrick Bronson Reeves, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3366 Nw Expressway Ste 550, Oklahoma City, OK 73112 Phone: 405-942-5442 Fax: 405-942-6448 | |
Dr. Jake Lee Evans, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 800 Stanton L Young Blvd, Aat 6300, Oklahoma City, OK 73104 Phone: 405-271-5963 | |
Metri Haddaden, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 800 Stanton L Young Blvd # 8425, Oklahoma City, OK 73104 Phone: 405-271-6173 Fax: 410-554-2184 | |
Divya Sharma Divyadarshini, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 800 Stanton L Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-5963 | |
Dr. Philip Barton Miner, Jr., M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1000 N Lincoln Blvd, Suite 210, Oklahoma City, OK 73104 Phone: 405-271-4644 Fax: 405-271-3296 | |
Gary Lee Worcester, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3433 Nw 56th St, Ste 400, Oklahoma City, OK 73112 Phone: 405-947-3341 |